Pharmaceutical research blends human creativity with technological innovation. This expansion of our state of the art chemistry research program will greatly improve our ability to discover new compounds for the treatment of cancer, diabetes, osteoporosis and obesity. Our goal is to improve the health of people worldwide. Gov. John G. Rowland said the Bayer expansion is further evidence that Connecticut is becoming the bioscience center of the Northeast. Every announcement we've made has been extremely welcome and this one at Bayer is no exception.
Bioscience provides tremendous job opportunities for Connecticut residents.
Projects like the one at Bayer continue to demonstrate that the future of young and talented college students belongs here in Connecticut. Both the State of Connecticut and the City of West Haven provided incentive packages that made it attractive for Bayer to expand in Connecticut. West Haven Mayor H. Richard Borer Jr. welcomed the news as a continuation of the excellent relationship between the City of West Haven and Bayer. Bayer has always been a good neighbor. The project is precipitated by recent alliances with Millennium Pharmaceuticals, Inc., and Lion Inc., which will result in Bayer receiving access to key technologies in modern genomic and bioinfomatic research.